Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations
Open Access
- 1 September 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (9) , 3407-3411
- https://doi.org/10.1128/aac.48.9.3407-3411.2004
Abstract
Resistance problems with caspofungin, an echinocandin inhibitor of fungal cell wall glucan synthesis, have been rare. We noted paradoxical turbid growth of Candida albicans isolates in broth in some high (supra-MIC) concentrations. Among isolates submitted for susceptibility testing and screened at drug concentrations up to 12.5 μg/ml, the frequency was 16%. Analysis of the turbid growth indicated slowing of growth in the presence of drug but with numbers of CFU up to 72% those of drug-free controls. Clearing of growth again by the highest drug concentrations produced a quadriphasic pattern in a tube dilution series. Cells growing at high drug concentrations were not resistant on retesting but showed the paradoxical effect of the parent. Among a selected series of isolates tested at concentrations up to 50 μg/ml, an additional 53% showed a “mini-paradoxical effect”: no turbid growth but incomplete killing at high concentrations (supra-minimum fungicidal concentration). These effects were reproducible; medium dependent in extent; noted in macro- and microdilution, in the presence or absence of serum, and on agar containing drug (but not when drug concentrations were not constant, as in agar diffusion); not seen with other echinocandins and less commonly in other Candida species; and not due to destruction of drug in tubes showing the effect. Cooperative enhancement of inhibition by a second drug could eradicate the effect. We postulate that high drug concentrations derepress or activate resistance mechanisms. The abilities of subpopulations to survive at high drug concentrations could have in vivo consequences.Keywords
This publication has 24 references indexed in Scilit:
- Addition of Caspofungin to Fluconazole Does Not Improve Outcome in Murine CandidiasisAntimicrobial Agents and Chemotherapy, 2003
- Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2003
- The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofunginMolecular Microbiology, 2003
- In Vitro Pharmacodynamic Properties of Three Antifungal Agents against PreformedCandida albicansBiofilms Determined by Time-Kill StudiesAntimicrobial Agents and Chemotherapy, 2002
- Resistance Mechanisms in Clinical Isolates of Candida albicansAntimicrobial Agents and Chemotherapy, 2002
- Molecular Epidemiology of the Global and Temporal Diversity of Candida albicansClinical Infectious Diseases, 1999
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Susceptibility of Candida albicans to flucytosine when tested in different formulations of yeast nitrogen base brothDiagnostic Microbiology and Infectious Disease, 1986
- Obfuscation of the Activity of Antifungal Antimicrobics by Culture MediaThe Journal of Infectious Diseases, 1972
- THE RATE OF BACTERICIDAL ACTION OF PENICILLIN IN VITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMSThe Journal of Experimental Medicine, 1948